AllyMack Inc., a South Dakota C Corporation, evolved from an initial focus on hemp-derived innovation, including THCV—a rare cannabinoid with potential benefits for appetite control, metabolic support, and mental clarity.
In 2025, we moved away from product development to become a capital deployment and search firm. Through our partnership with Havenfield Deal Partners, AllyMack now targets cash-flowing businesses and short-term projects that align with our mission and offer strong return potential and low risk.
Our lead initiative is an exclusive partnership with a top mass tort mediation firm. By financing structured mediated settlements, AllyMack helps resolve cases in months, bringing faster outcomes to claimants and delivering attractive, low risk returns to investors.